Nonsurgical Management of Heavy Menstrual Bleeding

Matteson, Kristen A.; Rahn, David D.; Wheeler, Thomas L.; Casiano, Elizabeth A; Siddiqui, Nazema Y.; Harvie, Heidi S.; Mamik, Mamta M.; Balk, Ethan M; Sung, Vivian W.

doi:10.1097/aog.0b013e3182839e0e

Cited by 132 publications

(75 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…TSH levels were advised to rule out occult hypothyroidism. Pap smears were taken and endometrial biopsy was taken [9]. The drug was administered orally in the form of 60 mg tablet twice weekly (every Sunday and Thursday) for the first 12 weeks and then once a week (every Sunday) for another 12 week.…”

Section: Methodsmentioning

confidence: 99%

Management of Acute Abnormal Uterine Bleeding in Nonpregnant Women

2016

IJSR

View full text Add to dashboard Cite

Chronic abnormal uterine bleeding (AUB), a term that refers to menstrual bleeding of abnormal quantity, duration, or schedule, is a common gynecologic problem, occurring in approximately 10 to 35 percent of women. We report the outcome of the treatment. This is a prospective cohort study of 87 women aged 28-46 years who attended the outpatient gynecology department over the period 2013-2014 to the Obstetric Gynecologic University Hospital "Queen Geraldine", in Tirana, Albania with complaint of heavy menstrual flow. 66.7% of patients had regular normal menses at 3 months follow up, 10% had amenorrhea and 6% were having regular scanty menses. Failure of medical management requires further investigation, including imaging or hysteroscopy. The choice of treatment of AUB is guided by the goals of therapy, which may be to stop acute bleeding, avoid future irregular or heavy bleeding, simultaneously provide contraception, and prevent complications, such as anemia, unnecessary surgical intervention, and diminished quality of life.

show abstract

Section: Methodsmentioning

confidence: 99%

Management of Acute Abnormal Uterine Bleeding in Nonpregnant Women

2016

IJSR

View full text Add to dashboard Cite

show abstract

“…However, data concerning treatment of patients, women with AUB presumed secondary to ovulatory dysfunction (AUB-O), are limited [5]. There are no randomized trials that evaluated the use of hormonal therapy specifically for the treatment of AUB-O [11].…”

Section: Summary Of First Line Laboratory Tests For Abnormal Uterine mentioning

confidence: 99%

“…In 2013, the Society of Gynecologic Surgeons Systematic Review Group published a review of 22 studies comparing non-surgical therapy for the treatment of AUB presumed due to endometrial dysfunction (AUB-E) [5].…”

Section: Aub-ementioning

confidence: 99%

Diagnosis and Management of Formerly Called “Dysfunctional Uterine Bleeding” According to PALM-COEIN FIGO Classification and the New Guidelines

Khrouf

Terras²

2014

J Obstet Gynecol India

View full text Add to dashboard Cite

In 2011, the FIGO classification system (PALM-COEIN) was published to standardize terminology, diagnostic and investigations of causes of abnormal uterine bleeding (AUB). According to FIGO new classification, in the absence of structural etiology, the formerly called ''dysfunctional uterine bleeding'' should be avoided and clinicians should state if AUB are caused by coagulation disorders (AUB-C), ovulation disorder (AUB-O), or endometrial primary dysfunction (AUB-E). Since this publication, some societies have released or revised their guidelines for the diagnosis and the management of the formerly called ''dysfunctional uterine bleeding'' according new FIGO classification. In this review, we summarize the most relevant new guidelines for the diagnosis and the management of AUB-C, AUB-O, and AUB-E.Keywords Abnormal uterine bleeding Á Dysovulation Á Menorrhagia Abnormal uterine bleeding (AUB) has negative impact on women's health and well-being inducing anemia, impacting their quality of life by impairing sexuality, and leads to absenteeism and social embarrassment. Non-structural abnormal uterine bleeding, or the formerly called dysfunctional menometrorrhagia, is a frequent cause of AUB.Until recently, there was confusion in clinical management and in the interpretations of clinical trials due to a

show abstract

“…1 Similarly, authors of a recent systemic review on nonsurgical management of heavy menstrual bleeding recommend the use of the levonorgestrel intrauterine system over oral contraceptive pills (OCPs), luteal-phase progestins, and NSAIDs for the reduction of blood loss in women with heavy menstrual bleeding. 27 Based on the compelling evidence of overall efficacy and safety from numerous clinical trials, use of LNG-IUS can be considered as the first line therapy for Indian patients with heavy menstrual bleeding ( Figure 5). …”

Section: Place For the Use Of Lng-ius In Idiopathic Abnormal Uterine mentioning

confidence: 99%